Alto Neuroscience, Inc.
SEC CIK 1999480 · ANRO · last insider filing 2026-05-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Miller Andrew Craig | Director | filed 2026 - 2026 |
| Etkin Amit | Director · President and CEO | filed 2024 - 2026 |
| Dreyfus Andrew | Director | filed 2024 - 2026 |
| Sanchez Ramiro | Director | filed 2025 - 2026 |
| Cox Christopher Nixon | Director | filed 2024 - 2026 |
| York Gwill | Director | filed 2024 - 2026 |
| Manji Husseini | Director | filed 2024 - 2026 |
| Radhakrishnan Maha | Director | filed 2024 - 2024 |
| Chen Po Yu (Jeff) | Director | filed 2024 - 2024 |
| Alkeon Capital Management LLC | Director | filed 2024 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Smith Nicholas Conrad | Chief Financial Officer | filed 2024 - 2026 |
| Hanley Jr. Michael Conick | Chief Operating Officer | filed 2024 - 2026 |
| Savitz Adam | Chief Medical Officer | filed 2024 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.